LYMPHANGIECTASIA

This adverse event was reported 70 times

LYMPHANGIECTASIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Endoglycosidase [EPC] 1 0.0005
1 Provitamin D2 Compound [EPC] 7 0.0002
2 Somatostatin Analog [EPC] 1 0.0001
3 Allylamine Antifungal [EPC] 1 0.0001
4 Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] 1 0.0001
5 General Anesthetic [EPC] 5 0.0001
6 Sulfone [EPC] 1 0.0001
7 Bile Acid Sequestrant [EPC] 1 0.0001
8 Leukotriene Receptor Antagonist [EPC] 2 0.0001
9 Anti-IgE [EPC] 5 0.0001
See all drug classes enriched for association with LYMPHANGIECTASIA